| Literature DB >> 27416979 |
Rafael Boscolo-Berto1, Massimo Montisci2, Silvia Secco3, Carolina D'Elia4, Rosella Snenghi2, Guido Viel2, Santo Davide Ferrara2.
Abstract
A conflict of interest (COI) is a situation in which a person has competing loyalties or interests that make it difficult to fulfil his or her duties impartially. Conflict of interest is not categorically improper in itself but requires proper management. A SCOPUS literature search was performed for publications on the efficacy/safety of Phospho-Di-Esterase Inhibitors (PDEIs) for treating erectile dysfunction. A categorization tool (CoOpCaT) was used to review and classify the publications as supportive/not-supportive for the discussed active ingredient and reporting or not reporting a COI for that specific drug or for the remaining PDEIs (i.e. competitors). Multivariable binary logistic regression was performed. In the 419 selected records the prevalence of supportive opinions was higher when a COI for the index label was declared. The CoOpCaT showed good internal consistency, discriminative validity and intra/inter-rater agreement. The strongest predictor for a supportive opinion was the total number of financial COIs for the index label. A mild protective effect of the total number of financial COIs for any competitor label was noted. Financial COIs have frequently been associated with bias, and the measures currently adopted to restrain it lack effectiveness. Some evidence for monitoring and/or compensating this bias is reported here, but the ultimate solution remains distant.Entities:
Keywords: Bias; Conflict of interest; Ethics; Financial disclosure; Sponsor
Mesh:
Substances:
Year: 2016 PMID: 27416979 DOI: 10.1007/s11673-016-9732-2
Source DB: PubMed Journal: J Bioeth Inq ISSN: 1176-7529 Impact factor: 1.352